Global Asthma Therapy Market Size, Demand, Trends, Key Players & Growth Drivers 2021-2026 – Stillwater Current



According to the latest IMARC Group report, entitled “Asthma Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2021-2026“, The global asthma treatment market reached a value of US $ 17.6 billion in 2020. In the future, the market value is expected to reach US $ 19.13 billion by 2026, with a CAGR of 1.60% in 2021-2026.

Like the new coronavirus (COVID-19[FEMALE)[FEMININE) as the crisis takes hold of the world, we are constantly monitoring changes in the markets, as well as the buying behaviors of consumers around the world – our estimates on the latest market trends and forecast values ​​after considering the impact of this pandemic. These observations will be incorporated into the report.

Request a free copy of this report:

Asthma therapy includes a group of pharmaceutical drugs which are primarily used to treat asthma. The drugs help alleviate the symptoms of respiratory disease, which is usually triggered by exposure to various causative agents outdoors and indoors, including dust, allergens, pollutants, etc. Asthma treatments usually include bronchodilators and anti-inflammatory drugs, such as active beta-agonists (LABAs), methylxanthine, immunomodulators, corticosteroids, leukotriene modifiers, etc. These drugs help to expand the air passage in the lungs, which further allows the proper movement of air to improve the respiratory process. Therapeutic asthma drugs are usually administered via inhalers or nebulizers and are adopted in rapid-relief drugs and long-term asthma control therapies.

Market trends and drivers:

The increasing prevalence of asthma due to increasing levels of air pollution is currently propelling the adoption of asthma treatments. Moreover, the growing consumer awareness of the easy availability of effective asthma treatments is also catalyzing the growth of the asthma treatment market. In addition, the emergence of combination therapies for the treatment of respiratory diseases, such as asthma, is driving the demand for asthma therapies. Many pharmaceutical companies are constantly focusing on clinical trials of developing asthma drugs with superior efficacy and prolonged effect. Several other factors, including increased healthcare spending, continued upgrading of healthcare infrastructure, extensive R&D activities in the medical sector, etc., are expected to further strengthen the market in the coming years.

Asthma Therapeutics 2021-2026 Competitive Analysis and Segmentation:

Competitive landscape with key players:

The competitive landscape of the Asthma Therapeutics market has been studied in the report along with the detailed profiles of the major players operating in the market.

Some of these key players include:

  • Amgen Inc.
  • Dainippon Sumitomo Pharma Co. Ltd.
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • F. Hoffmann-La Roche SA
  • Biogen Inc.
  • Merck & Co. Inc.
  • AstraZeneca
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc.

Key market segmentation:

The report has segmented the global asthma treatment market on the basis of drug class, product type, treatment type, route of administration, and region.

Breakdown by drug class:

  • Anti-inflammatory drugs
  • Bronchodilators
  • Combined therapies

Breakdown by product type:

  • Inhalers
    • Dry powder inhalers
    • Metered-dose inhalers
    • Soft mist inhalers
  • Nebulizers
    • Pneumatic nebulizers
    • Ultrasonic nebulizers
    • Mesh nebulizers

Breakage by type of treatment:

  • Fast-relief medications
  • Drugs for long-term asthma control

Breakdown by administration route:

  • Inhalation
  • Oral
  • Parenteral

Breakdown by region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Explore the full report with table of contents and list of figures:

Highlights of the report:

  • Market performance (2015-2020)
  • Market Outlook (2021-2026)
  • Porter’s Five Forces Analysis
  • Market drivers and success factors
  • SWOT analysis
  • The impact of COVID-19 on the global market
  • Value chain analysis
  • Global market structure
  • Complete mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as part of the customization.

About Us

The IMARC group is a leading market research company providing management strategies and market research worldwide. We partner with clients across industries and regions to identify their most exciting opportunities, address their most critical challenges and transform their businesses.

IMARC’s information products include leading business, scientific, economic and technological developments for business leaders in the biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism and nanotechnologies. We also provide cost model and manufacturing configuration project reports through Syndicated Analytics, a subsidiary of IMARC Group.

Our offerings include comprehensive market information in the form of research reports, production cost reports, feasibility studies and consulting services. Our team, which includes experienced researchers and analysts from a variety of industries, is dedicated to delivering high-quality data and information to our customers, ranging from small and medium-sized businesses to Fortune 1000 companies.

Contact us:
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Americas: + 1-631-791-1145 | Europe & Africa: + 44-753-713-2163 | Asia: + 91-120-433-0800


Leave A Reply

Your email address will not be published.